Home › Leukemia › Connecticut › Hartford
Leukemia clinical trials in Hartford, CT
5 studies for Leukemia are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Hartford HealthCare Cancer Institute, Hartford
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RecruitingObservational study
- Connecticut Children's Medical Center, Hartford
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
RecruitingObservational study
- Connecticut Children's Medical Center, Hartford
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hartford
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer10 studies
- Lung Cancer10 studies
- Cancer (all types)9 studies
- Major Depressive Disorder8 studies
- Neuroblastoma8 studies
- Ovarian Cancer7 studies
- Prostate Cancer7 studies
- Heart Failure7 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.